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Abstract We have studied the interactions between the ribo-
some and the domains of Escherichia coli translation initiation
factor 2, using an in vitro ribosomal binding assay with wild-type
forms, N- and C-terminal truncated forms of IF2 as well as
isolated structural domains. A deletion mutant of the factor
consisting of the two N-terminal domains of IF2, binds to both
30S and 50S ribosomal subunits as well as to 70S ribosomes.
Furthermore, a truncated form of IF2, lacking the two N-
terminal domains, binds to 30S ribosomal subunits in the
presence of IF1. In addition, this N-terminal deletion mutant
IF2 possess a low but significant affinity for the 70S ribosome
which is increased by addition of IF1. The isolated C-terminal
domain of IF2 has no intrinsic affinity for the ribosome nor does
the deletion of this domain from IF2 affect the ribosomal binding
capability of IF2. We conclude that the N-terminus of IF2 is
required for optimal interaction of the factor with both 30S and
50S ribosomal subunits. A structural model for the interaction of
IF2 with the ribosome is presented.
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1. Introduction
In prokaryotes, three initiation factors IF1, IF2 and IF3
interact with the 30S ribosomal subunit to promote the for-
mation of a protein synthesis initiation complex between the
small ribosomal subunit, mRNA and fMet-tRNAMetf . The ini-
tiation complex formation as well as the postulated role of all
three factors have been extensively reviewed [1^4]. IF2 is the
largest of the factors and is expressed, in E. coli, in three
di¡erent forms in vivo di¡ering in the N-termini : IF2K (97.3
kDa), IF2L (79.7 kDa) and IF2Q (78.8 kDa) [5]1. The function
of IF2 is to stimulate the binding of fMet-tRNAMetf to ribo-
somes during formation of 30S and 70S initiation complexes
followed by the hydrolysis of GTP to GDP and Pi. The bind-
ing site(s) of IF2 on the 30S and 50S ribosomal subunits has
been studied for more than two decades by cross-linking
methods [7^12]. It appears that IF2 binds to the ribosome
essentially by protein-protein interactions covering a large
part of the head and platform of the 30S ribosomal subunit
and, in addition, interacts with the L7/L12 stalk in the 50S
subunit. On the contrary, less is known concerning which
regions of IF2 are involved in the binding of the factor to
the ribosome. Since IF2 exists in E. coli in three forms di¡er-
ing in only the N-terminus and di¡erent N-terminal truncated
forms have been shown to possess similar activities in vitro
and in vivo, it has been proposed that the active centers for
interaction with fMet-tRNAMetf , ribosomes and GTP would
reside within the C-terminal half of the protein leaving the
N-terminus of IF2 functionally uncharacterized [13^15].
In a recent paper we have shown the interaction of a series
of truncated forms and isolated domains of IF2 (Fig. 1) and
the 30S ribosomal subunits in the absence of fMet-tRNAMetf ,
mRNA, IF1 and IF3 [16]. We concluded that the N-terminus
of IF2 had a⁄nity per se to bind the 30S ribosomal subunits
with domain II being directly involved in the interaction.
Moreover, we could unexpectedly conclude that the mutant
IF2 domains III^VI (see Fig. 1) showed a negligible a⁄nity
for the ribosomal subunit. In the present paper we have ex-
tended our studies of the domains of IF2 involved in the
binding to the ribosome by including 50S and 70S ribosomes
as well as IF1 and IF3 aiming at de¢ning a model for the
interaction of IF2 with the ribosome and, moreover, revisiting
the functions of IF1 and IF3. The discussion of the results
obtained will be related to our six-domain structural model
for IF2 described in [17].
2. Materials and methods
2.1. Chemicals
All the chemicals used were of analytical grade from Merck or
Sigma unless otherwise indicated.
2.2. Bu¡ers
Ribosome binding bu¡er: 10 mM Tris-HCl (pH 7.6), 10 mM
MgCl2, 100 mM NH4Cl, 1 mM DTT, 2 mM GTP.
2.3. IF2K and IF2L
Both native forms of the initiation factor were overexpressed and
puri¢ed essentially as described by Mortensen et al. [18].
2.4. Truncated forms of IF2
Construction, overexpression and puri¢cation of N-terminal and C-
terminal deletion mutants as well as isolated domains of IF2 were
carried out essentially as described in [16^18].
2.5. Cloning, expression and puri¢cation of IF1
The gene infA, encoding IF1, was ampli¢ed from E. coli MRE600
genomic DNA by PCR using degenerate primers introducing restric-
tion sites for BamHI and EcoRI and a protease factor Xa cleavage
site. The PCR product was cloned into the gene fusion system pGEX-
1 [19]. The plasmid was transformed into E. coli UT5600 cells [20] and
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overexpression and puri¢cation was performed essentially as described
in [19].
2.6. Expression and puri¢cation of IF3
E. coli UT5600[pCI857] cells were transformed with plasmid
pIM201 carrying the gene infC (kindly provided by M. Springer)
[21]. IF3 was overexpressed essentially as described for IF2 in [18]
and puri¢ed as in [22].
2.7. Preparation of 30S and 50S ribosomal subunits
Ribosomes were prepared from MRE600 E. coli cells essentially as
described in [23] and 30S and 50S ribosomal subunits isolated by
zonal centrifugation as described in [16].
2.8. 30S, 50S and 70S binding assays
The ribosomal binding assays were performed essentially as de-
scribed in [16]. Ribosomal subunits were incubated in ribosomal bind-
ing bu¡er (¢nal reaction volume 50 Wl) for 10 min at 37‡C prior to
mixing with di¡erent truncated forms of IF2 and equimolar amounts
of IF1 and IF3. Incubation, ultracentrifugation and subsequent anal-
ysis of supernatants and pellets was performed as described in [16].
3. Results
It was recently shown that IF2 domains I^II (see Fig. 1)
bind to the 30S ribosomal subunits whereas IF2 domains III^
VI do not [16]. In this work we have studied the e¡ect of IF1
and IF3 on the binding of truncated forms of IF2 to the 30S
and 50S ribosomal subunits and to 70S reconstituted ribo-
somes.
3.1. Interaction of IF2 with the 30S ribosomal subunits
Results are shown in Figs. 2 and 3 and summarized in
Table 1. The addition of IF1 and IF3 do not further stimulate
the binding of wild-type IF2 (IF2K and IF2L) or C-terminal
deletion mutants IF2 domains I^V, IF2 domains I^IV and
IF2 domains I^II to the 30S ribosomal subunit. Furthermore,
neither IF2 domain I nor IF2 domain VI can bind to the 30S
ribosomal subunits under any experimental conditions includ-
ing IF1 and/or IF3. Results including IF2 domains III^VI in
the ribosomal binding assay are striking since this mutant of
IF2, which is lacking the two N-terminal domains, can only
bind to the 30S ribosomal subunit in the presence of IF1 (see
Fig. 3), whereas IF3 has no stimulatory binding e¡ect either
alone or together with IF1. Therefore, the signi¢cant stimula-
tory binding e¡ect of IF1 may be caused by interactions with
regions of IF2 located within the C-terminal two thirds of the
molecule and, in addition, the speci¢c strong interaction be-
tween the N-terminus of IF2 and the ribosome, would mask
Fig. 1. Schematic representation of the three naturally existing forms of IF2: IF2K, L and Q, as well as the N-terminal and C-terminal deletion
mutants. The domains of IF2 are numbered I^VI according to the six domain model proposed in [16], where domain IV is the GTP binding
domain.
Fig. 2. SDS-PAGE and Coomassie brilliant blue G staining of pel-
lets after ultracentrifugation of 30S ribosomal assay. The di¡erent
recombinant IF2 proteins, as well as IF1 or IF3 when present, were
incubated with 30S ribosomal subunits in an equimolar amount (2
WM) and the incubation was subsequently ultracentrifuged. In the
absence of ribosomes no truncated proteins were found in the pellet
(not shown). IF3 (20.5 kDa) and IF1 (8.1 kDa) are not seen in the
gel.
Fig. 3. SDS-PAGE and Coomassie brilliant blue G staining of
supernatant and pellet samples after ultracentrifugation of IF2 do-
mains III^VI 30S ribosomal assay.
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the stimulatory e¡ect of IF1 on IF2 forms containing N-ter-
minal domains.
3.2. Interaction of IF2 with the 50S ribosomal subunits
E. coli IF2 binds less e⁄ciently to the 50S ribosomal sub-
units than to the 30S as previously reported for Bacillus stearo-
thermophilus IF2 in [24]. However, it was possible clearly to
detect the binding of wild-type IF2 forms and moreover study
the binding e⁄ciency of truncated forms of the factor to the
large ribosomal subunit. Deletion of 600 C-terminal amino
acids does not signi¢cantly decrease the ability of IF2 to in-
teract with the 50S ribosomal subunit (see Fig. 4 and sum-
mary in Table 1).
On the contrary, the binding of IF2 domains III^VI, where
the two N-terminal domains are deleted, to the 50S subunits
was drastically reduced although not completely abolished as
described for the binding to 30S ribosomal subunits (see Fig.
3). This result implies a closer contact between C-terminal
domains of IF2 and the 50S ribosomal subunit than to the
30S subunit. Neither IF1 nor IF3 promoted the binding of
IF2 domains III^VI and, in addition, neither IF2 domain I
nor IF2 domain VI interacts with the large ribosomal subunit
as reported for the 30S subunits.
3.3. Interaction of IF2 with the 70S ribosomes
Similar binding patterns as found for IF2 to the ribosomal
subunits are found with the 70S ribosome, e.g. C-terminal
sequential deletions do not signi¢cantly a¡ect the binding of
IF2 and the C-terminal domain VI and N-terminal domain I
are not interacting with the ribosome. Despite of the lack of
a⁄nity of IF2K domains III^VI for the 30S, and low a⁄nity
for the 50S, ribosomal subunits, this mutant IF2 can bind to
the 70S reconstituted ribosome in absence of IF3 or IF1 (Fig.
5). However, IF1 stimulates the binding of IF2 domains III^
VI fragment as shown for the 30S ribosomal subunits (see
Figs. 3 and 5). Consequently, it can be postulated a synergetic
e¡ect which would, somehow, stabilizes the IF2 mutant
bound to the reconstituted 70S ribosome.
4. Discussion
The present study together with [16] present new informa-
tion concerning the interaction of IF2 with the ribosome. A
model is proposed in which the main active center for the
binding of IF2K to the ribosome is within the N-terminal
domain II. The N-terminal domain I and the C-terminal do-
main VI are devoid of interaction with the ribosome and in
addition, the two third C-terminal domains do not directly
interact with the 30S ribosomal subunit, but interacts weakly
with 50S and 70S ribosomes. Furthermore, IF1 is involved in
the binding of IF2 to the 30S ribosome by direct interaction
with regions located within IF2 domains III^V. The proposed
model corrects earlier conclusions that the active centers on
IF2 for the interaction with fMet-tRNAMetf , ribosomes and
GTP would reside within the C-terminal two thirds of IF2,
leaving the N-terminus of IF2 functionally uncharacterized
[4,13,14]. It was observed that IF1 and IF3 greatly in£uence
the activity, in vitro, of the IF2 domains III^VI, in that work
termed IF2Q, as compared to IF2K [13], and, in vivo, the lack
of N-terminal domains of IF2K abolish the cell growth at
37‡C [14]. These results are consistent with the model we
propose in which IF1 stimulates the binding of IF2 and where
the N-terminus of IF2 is important for the binding to the
ribosome.
Based on these results together with published data of IF2
Table 1
Binding e⁄ciency to the 30S, 50S and 70S ribosomes of di¡erent
native and truncated forms of IF2 in absence (3) or presence (+) of
IF1
Values represented come from the analysis of the protein bound to
the ribosomes in the pellet as well as the non-bound fraction present
in the supernatant, subsequently being compared with experiments
in the absence of ribosomal subunits. +++, 80^100%; ++, 40^80%;
+, 10^40%; 3, 0^10%; n.d., not determined.
Fig. 4. SDS-PAGE and Coomassie brilliant blue G staining of pel-
lets after ultracentrifugation of 50S ribosomal assay. In the absence
of ribosomes no truncated proteins were found in the pellet (not
shown).
Fig. 5. SDS-PAGE and Coomassie brilliant blue G staining of
supernatant and pellet samples after ultracentrifugation of IF2 do-
mains III^VI 70S ribosomal assay.
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cross-linking and three-dimensional structure of ribosomes
and translation factors, we are proposing a structural model
for the interaction of IF2 and the 30S ribosome (Fig. 6). No
NMR or X-ray crystallographic model exists for IF2. How-
ever, from the three-dimensional reconstruction of the ribo-
some [26,27] it can be deduced that IF2 must be a relatively
large molecule to achieve the interaction with proteins located
in the head as well as the platform of the 30S ribosomal
subunit [7,10] and with proteins L7 and L12 in the 50S ribo-
somal stalk [8], covering a distance of approximately 10 nm
[26]. This interaction may be archieved stericly by an IF2 with
the overall dimension of 9.0U9.9U9.6 nm, which was esti-
mated from the radius of gyration determined by small angle
neutron scattering experiments on E. coli IF2K [28]. The bind-
ing location of the di¡erent domains of IF2 on the ribosome
are proposed as follows:
4.1. IF2 domain I
The N-terminal domain of IF2K does not possess intrinsic
a⁄nity for the 30S, 50S or 70S ribosome. Moreover, mono-
clonal antibodies with epitopes mapped within domain I do
not a¡ect the binding of IF2 to the 30S ribosomal subunit
[16]. The fact that IF2K and IF2L are both active in vitro and
in vivo, leaves domain I functionally uncharacterized [5,29].
The N-terminal domain I would be located between the head
and the platform in a solvent exposed area, consistent with
the high hydrophilicity proposed for the N-terminus of IF2
[30].
4.2. IF2 domain II
Cross-linking results from [7,10,11] showed that IF2 covers
part of the head and platform of the 30S ribosomal subunit.
Since IF2 domain II was shown to be directly involved in the
binding of the factor to the ribosome [16], we belief that
domain II covers the cross-linked areas. This can explain
the results of Yusupova et al. [31], who found cross-linking
between amino acid residues in IF2 domain II and the anti-
codon arm of the fMet-tRNAMetf located in the ribosomal P-
site. Furthermore, the binding of IF2 domains I^II to the 50S
ribosomal subunit is feasible considering that the association
between 30S and 50S ribosomal subunits involves the part of
the 30S platform [32], where the N-terminus of IF2 is located
in the proposed model.
4.3. IF2 domain III
This domain is the link between domain IV and domain II
[17].
4.4. IF2 domain IV
Earlier results have shown that protein L7/L12 was directly
involved in the GTPase activity of IF2 [33,34], and that L7/
L12 could be cross-linked to IF2 [8]. More recently, the vis-
ualization of other GTP binding translation factors on the
ribosome has been able to con¢rm the location of the struc-
turally homologous GTP binding domain close to the L7/L12
stalk [35,36]. Therefore, in our model (Fig. 6), domain IV of
IF2 is located opposite of the 30S platform which will permit
close contact with the 50S L7/L12 stalk.
4.5. IF2 domain V
A model based on the analysis of sequence homologies in
which Thermus thermophilus IF2 domain III (E. coli IF2 do-
main V) together with IF1 would mimic the structure of the
elongation factor G at the ribosomal A-site was recently pro-
posed [37,38]. This hypothesis, together with the cross-linking
results reported for IF2-IF1 [10], are consistent with the re-
sults presented in this work showing that IF1 stimulates the
binding of IF2 to the 30S ribosomal subunit by interaction
with regions located within domains III^V. Furthermore, the
¢nding that amino acid residues within IF2 domain V cross-
link to the T-arm of the fMet-tRNAMetf [31], and the putative
arrangement of the initiator tRNA on the ribosome [25],
makes it feasible to locate IF2 domain V close to the riboso-
mal A-site, on the 50S ribosomal side.
4.6. IF2 domain VI
The C-terminal domain is believed to contain the fMet-
tRNAMetf recognition site of IF2 [39]. Supporting this hypoth-
esis, we found that a deletion mutant of IF2 lacking the C-
terminal 90 amino acid residues was unable to protect the
fMet-tRNAMetf against spontaneous deacylation or promote
its binding to the ribosome (data not shown). In addition,
foot-printing experiments have revealed that IF2 covers the
T-loop and the acceptor stem of the initiator tRNA [40].
Therefore, we locate the C-terminal domain of IF2 in close
contact with the fMet-tRNAMetf which occupies the P-site on
the ribosome but not necessarily binding to it, as revealed
from the lack of a⁄nity of domain VI for the ribosome.
A structural model for the interaction of IF2 with the ri-
bosome is proposed in which IF2 is initially recognized from
the solvent by interactions between domain II and the 30S
ribosomal subunit and subsequently positioned at the correct
location by IF1. The interaction with the 50S subunit occurs
through IF2 domain II and the G domain. IF3 is not involved
in the interaction.
Guanosine nucleotides were not involved in the assays.
However, further experiments are going on to re¢ne the pro-
posed model.
Fig. 6. Model for the interaction of E. coli IF2 and the ribosome.
The 30S ribosomal subunit is schematically represented from the
side that faces the 50S subunit (adapted from [25]). Transfer RNA
binding sites, A and P are moreover included. The six-domain mod-
el of IF2 is adapted from [17]. Whereas domain IV is in close con-
tact with the 50S L7/L12 stalk, the N-terminal domains would be
located covering part of the head and platform of the 30S riboso-
mal subunit.
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